Mortality Profile of COVID-19 Co-Infection in HIV/AIDS Patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Downloads
Highlights:
-
The majority of HIV/AIDS patients who succumbed to the effects of co-infection at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, were of productive age, with the predominant complications being anemia and bacterial infections.
-
Tuberculosis was listed as the most common opportunistic infection that exacerbated the condition of HIV/AIDS patients and caused death during the ongoing pandemic of COVID-19.
Abstract
Introduction: Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) is an immune system disease caused by the HIV infection, making individuals susceptible to various diseases, including coronavirus disease (COVID-19). Co-infection in HIV/AIDS patients can worsen the severity of the diseases, especially in those with comorbidities, complications, and opportunistic infections, potentially leading to death. This study aimed to determine the mortality profile of COVID-19 co-infection in HIV/AIDS patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from January 2020 to December 2022.
Methods: This study employed a descriptive cross-sectional method, utilizing secondary data from 48 medical records of COVID-19 co-infection in HIV/AIDS patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from January 2020 to December 2022, collected through a total sampling technique.
Results: Of the 105 total HIV/AIDS patients with COVID-19 co-infection, 48 were selected in this study based on predefined inclusion and exclusion criteria. The mortality profile showed a predominance of males (75%), with an average age of 36.5 years. The most common comorbidity was bacterial infection (38.6%), with the highest complication being anemia (55.6%), and the most prevalent opportunistic infection being tuberculosis/TB (50%).
Conclusion: The mortality profile of COVID-19 co-infection in HIV/AIDS patients indicated a higher occurrence among males, with an average age of 36.5 years old. The most common comorbidity was bacterial infection, whilst the most prevalent complications include anemia, with TB being the most frequent opportunistic infection.
World Health Organization (WHO). Global HIV Programme. Geneva, (2022). [Website]
Ministry of Health of the Republic of Indonesia (Kementerian Kesehatan Republik Indonesia). Situasi COVID-19. Jakarta. [Website]
Hu B, Huang S, Yin L. The Cytokine Storm and COVID-19. J Med Virol 2021; 93: 250–256. [PubMed]
Heidary M, Asadi A, Noorbakhsh N, Dashtbin S, Asadollahi P, Dranbandi A, et al. COVID-19 in HIV-Positive Patients: A Systematic Review of Case Reports and Case Series. J Clin Lab Anal 2022; 36: e24308. [PubMed]
Brown LB, Spinelli MA, Gandhi M. The Interplay between HIV and COVID-19: Summary of the Data and Responses to Date. Curr Opin HIV AIDS 2021; 16: 63–73. [PubMed]
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069. [PubMed]
Hidayat E, Bakar A, Nursalam N, Indarwati R, Maria H. Final Condition of HIV Patients Infected with COVID-19 after Receiving Hospital Treatment: A Systematic Review. J Respirasi 2023; 9: 56–63. [Journal]
Ranganathan P, Aggarwal R. Study Designs: Part 1 - An overview and Classification. Perspect Clin Res 2018; 9: 184–186. [PubMed]
Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, et al. Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019. Clin Infect Dis 2020; 71: 2294–2297. [PubMed]
Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV Infection Co-Pandemics and Their Impact: A Review of the Literature. AIDS Res Ther 2021; 18: 28. [PubMed]
Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among People Living with HIV: A Systematic Review. AIDS Behav 2021; 25: 85–92. [PubMed]
Pribadi GS, Cahyono ABF. Characteristics and Opportunistic Infections of AIDS Patients in East Java Province in 2018. J Berk Epidemiol 2021; 9: 96–104. [Journal]
Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and Outcomes of COVID-19 in HIV-Infected Individuals: A Systematic Review and Meta-Analysis. Sci Rep 2021; 11: 6283. [PubMed]
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 934–943. [PubMed]
Charlson ME, Wells MT. Comorbidity: From a Confounder in Longitudinal Clinical Research to the Main Issue in Population Management. Psychother Psychosom 2022; 91: 145–151. [Journal]
Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, et al. Causes of Death and Comorbidities in Hospitalized Patients with COVID-19. Sci Rep 2021; 11: 4263. [PubMed]
Jannah SN, Arfijanto MV, Rusli M, Widodo ADW. Sepsis: Antibiotic Resistances of Gram-Positive and Gram-Negative Bacterial in a Tertiary Care Hospital. JUXTA J Ilm Mhs Kedokt Univ Airlangga 2021; 12: 29–37. [Journal]
Xie B, Huang W, Hu Y, Dou Y, Xie L, Zhang Y, et al. Anemia and Opportunistic Infections in Hospitalized People Living with HIV: A Retrospective Study. BMC Infect Dis 2022; 22: 912. [Journal]
Abioye AI, Andersen CT, Sudfeld CR, Fawzi WW. Anemia, Iron Status, and HIV: A Systematic Review of the Evidence. Adv Nutr 2020; 11: 1334–1363. [PubMed]
Firnadi LPP, Setyoningrum RA, Suwandi MYS. Profile of Tuberculosis in Children and Adolescent at Dr. Soetomo General Hospital Surabaya. JUXTA J Ilm Mhs Kedokt Univ Airlangga 2022; 13: 42–45. [Journal]
Rahmawati A, Utomo B, Makhfudli M. Contact Investigation and Preventive Therapy as Tuberculosis prevention in Children with Tuberculosis Household Contact: A Systematic Review. J Ners 2020; 15: 178–187. [Journal]
Copyright (c) 2025 Catur Ifda Januarti, Musofa Rusli, Jusak Nugraha, Dwiyanti Puspitasari

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).